Pregnancy: There are insufficient data on the use of salmeterol and fluticasone propionate during pregnancy. Administration of drugs to pregnant women should only be considered if the expected benefit to the mother is greater than any possible risk to the fetus.
Lactation: There are no data available for human breast milk. Administration of salmeterol and fluticasone propionate to women who are breastfeeding should only be considered if the expected benefit to the mother is greater than any possible risk to the child.